Sino Biological™ EPHA4 Recombinant Human Protein (without Catalytic Activity Domain), His Tag

This recombinant protein was expressed from a DNA sequence encoding the human EPHA4 (NP_031962.2) extracellular domain (Met 1-Thr 547) was expressed, with a polyhistidine tag at the C-terminus

Overview
Brand: Invitrogen

Manufacturer Part Number: 11314H08H50

EPHA4 RECOMBINANT HUMAN PROTEIN (WITHOUT CATALYTIC

UNSPSC: 12352202

Additional Details:
Additional Details: Weight: 0.10000kg



Disclaimers: For Research Use Only. Not for use in diagnostic procedures.

Product Code. 15258525

Quantity Price
1 £ 217.0 / 50µg
Estimated Shipment date
from Supplier 07-12-2016
Add to basket


Description and Specification

Specification

For Use With (Application) Proteins, Expression, Isolation & Analysis; Enzyme & Protein Activity Assays; Protein Assay Controls, Reference Standards & Accessories
Quantity 50μg
Storage Requirements Store at -20°C. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles. Expires one year from date of receipt when stored as instructed.
Protein Family Other Proteins

Eph Receptor A4 (EPHA4), recombinant human protein is supplied as a lyophilized powder. It is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications. Since this product is a truncated protein and does not contain intracellular catalytic activity domain, it is not suitable for use in enzyme activity studies.
  • Activity: Measured by its ability to bind biotinylated Human EphrinA5-his (Mfr. No. 10192-H08H) in functional ELISA
  • Formulation: 140mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4, 5% Mannitol, 5% Trehalose, 0.02% Tween 80
  • Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2mg/mL or lower; aliquot and use as soon as possible

This protein is manufactured by Sino Biological Inc.